- cafead Mar 30, 2023 at 11:12: PM
via BriaCell Therapeutics is plucking a couple of preclinical mixtapes and seeing how they sound in a new studio, forming a fresh spinout company to develop the early meds.
The new company, which has been dubbed SpinCo in the release, will have a preclinical PKCδ inhibitor and immunotherapy, BriaCell announced Thursday morning. The new entity will be majority-owned and controlled by BriaCell, and existing BriaCell shareholders will be able to buy in. Once the transaction is complete, BriaCell shareholders will receive one share of the slimmed-down BriaCell and one share of SpinCo.
article source
The new company, which has been dubbed SpinCo in the release, will have a preclinical PKCδ inhibitor and immunotherapy, BriaCell announced Thursday morning. The new entity will be majority-owned and controlled by BriaCell, and existing BriaCell shareholders will be able to buy in. Once the transaction is complete, BriaCell shareholders will receive one share of the slimmed-down BriaCell and one share of SpinCo.
article source